Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Elanco Animal Health Incorporated (ELAN)

20.62   0.99 (5.04%) 07-02 20:20
Open: 19.6 Pre. Close: 19.63
High: 20.655 Low: 19.545
Volume: 6,338,400 Market Cap: 9,776(M)
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 20.7 - 20.84 20.84 - 20.96
Low: 19.22 - 19.39 19.39 - 19.54
Close: 20.35 - 20.63 20.63 - 20.88

Technical analysis

as of: 2022-07-01 4:21:34 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 26.62     One year: 29.11
Support: Support1: 19.34    Support2: 16.09
Resistance: Resistance1: 22.79    Resistance2: 24.93
Pivot: 20.42
Moving Average: MA(5): 20.17     MA(20): 21.22
MA(100): 24.67     MA(250): 28.57
MACD: MACD(12,26): -1     Signal(9): -1
Stochastic oscillator: %K(14,3): 22.6     %D(3): 14.8
RSI: RSI(14): 42.2
52-week: High: 37.49  Low: 19.34
Average Vol(K): 3-Month: 4,730 (K)  10-Days: 5,708 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ELAN ] has closed below upper band by 39.8%. Bollinger Bands are 45.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sat, 02 Jul 2022
IFM Investors Pty Ltd Buys 8624 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Fri, 01 Jul 2022
Elan Cup 2022 to take place in Venice on the 23rd of July - Sail World

Thu, 30 Jun 2022
Jonathan Majors Signs With WME - Deadline

Thu, 30 Jun 2022
Professional Winter Sports Equipment Market is Booming Worldwide with Amer Sports, ELAN, DOO – Designer Women - Designer Women

Thu, 30 Jun 2022
Industrial Ceramics Market 2022 Competitive Insights – Kyocera, CM Cera, Anderman Ceramics, Elan Technology – Designer Women - Designer Women

Mon, 27 Jun 2022
Elan to Restart Production of Bicycles - Total Slovenia News

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 473 (M)
Shares Float 425 (M)
% Held by Insiders 4.1 (%)
% Held by Institutions 105.6 (%)
Shares Short 16,130 (K)
Shares Short P.Month 14,380 (K)

Stock Financials

EPS -1.43
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 16.23
Profit Margin (%) -10
Operating Margin (%) 7.8
Return on Assets (ttm) 1.3
Return on Equity (ttm) -5.9
Qtrly Rev. Growth -2.3
Gross Profit (p.s.) 5.68
Sales Per Share 10.08
EBITDA (p.s.) 2.19
Qtrly Earnings Growth 0
Operating Cash Flow 483 (M)
Levered Free Cash Flow 785 (M)

Stock Valuations

PE Ratio -14.42
PEG Ratio 1.3
Price to Book value 1.26
Price to Sales 2.04
Price to Cash Flow 20.19

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.